Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute myelogenous leukemia with T-cell features.

V Ribrag1, C Bayle, P Brault

  • 1Département de médecine, institut Gustave-Roussy, Villejuif, France.

Bulletin Du Cancer
|January 1, 1992
PubMed
Summary

Four cases of acute myelogenous leukemia (AML) showed mixed cell lineage with T-lymphoid markers. Standard AML therapy was ineffective, but lymphoblastic leukemia regimens achieved remission, suggesting a distinct entity requiring alternative treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary Impact Trajectories of a Psychoeducational Program for Nursing Home Caregivers: Insights from Clinical Case Studies.

International medical case reports journal·2025
Same author

Investigation of fullerene cluster growth mechanisms by carbon atom addition using classical molecular dynamics.

The Journal of chemical physics·2023
Same author

Extracellular heat shock protein 70 levels in tumour-bearing dogs and cats treated with radiation therapy and hyperthermia.

Veterinary and comparative oncology·2023
Same author

Binary and ternary Pt-based clusters grown in a plasma multimagnetron-based gas aggregation source: electrocatalytic evaluation towards glycerol oxidation.

Nanoscale advances·2022
Same author

Infant botulism: Report of a misleading case and important key messages.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
Same author

The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas.

Clinical and translational radiation oncology·2021

Area of Science:

  • Hematology
  • Immunophenotyping
  • Leukemia Research

Background:

  • Acute myelogenous leukemia (AML) is a heterogeneous disease.
  • Accurate classification is crucial for effective treatment strategies.

Observation:

  • Four cases (4.3%) of newly diagnosed AML exhibited mixed cell lineage.
  • Morphological and cytochemical analysis classified these as myelogenous leukemias.
  • Immunophenotyping revealed T-lymphoid markers (CD2, CD5, CD7, cytoplasmic CD3) on blast cells.
  • Three cases co-expressed myelogenous markers (CD13, CD33).
  • All cases presented with a normal karyotype.

Findings:

  • Standard AML therapy failed to induce complete remission in two patients.
  • Treatment with lymphoblastic leukemia regimens resulted in complete remission in three cases.

Related Experiment Videos

  • One patient achieved long-term disease-free survival (>18 months) with this alternative approach.

    • Implications:

    • Mixed lineage leukemia with T-lymphoid markers represents a distinct clinicobiological entity.
    • Patients may benefit from alternative therapeutic strategies, including those used for lymphoblastic leukemia.
    • Further research into the unique characteristics and optimal treatment of this AML subtype is warranted.